Results 151 to 160 of about 488,286 (382)
Toward Saving Nozick from Kripke [PDF]
, 2003 Tracking theories of knowledge, though quite popular have been under attack from their inception. Specifically, we have in mind the attacks of Saul Kripke. We don"t think these attacks on tracking theories work.
Adams, Fred
core
RESPONSES TO ANALGESICS AND PLACEBO—STATISTICAL ANALYSIS
, 1957 H.H. Keasling, E Gross
openalex +1 more source
Methotrexate compared with placebo in lung cancer [PDF]
, 1977 Oleg S. Selawry +9 more
openalex +1 more source
Back Again to the Future: A New Era for Cerebroprotection
Annals of Neurology, EarlyView.Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source
Journal of Clinical and Translational ScienceOBJECTIVES/GOALS: Platform trials gain efficiency by sharing placebo controls among different study arms. However, the varying routes of administration make it unclear whether participants exposed to different placebos have similar outcomes.
Yue Gao +3 more
doaj +1 more source
Ventricular fibrillation in experimental hypothermic cardiac surgery, the evaluation of antifibrillary agents [PDF]
, 1959 Thesis (M.A.)--Boston ...
Anlyan, Frederick H.
core +1 more source
Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. [PDF]
, 1975 Graham Jackson, L Atkinson, S. Oram
openalex +1 more source
Annals of Neurology, EarlyView.Objective Biomarkers with clear contexts of use are important tools for amyotrophic lateral sclerosis (ALS) therapy development. Understanding their longitudinal trajectory in the untreated state is key to their use as potential markers of pharmacodynamic response.
Oleksandr Dergai +16 more
wiley +1 more source